AIM ImmunoTech logo
AIM ImmunoTech AIM
$ 0.21 6.65%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

AIM ImmunoTech Balance Sheet 2011-2024 | AIM

Annual Balance Sheet AIM ImmunoTech

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-26.2 M -31.9 M -38.5 K 4.91 M 5.63 M 423 K -2.41 M -2.11 M -2.13 M -747 K -2.11 M -1.03 M

Long Term Debt

659 K 112 K - 3.91 M - 1.84 M - - - - - 380 K

Long Term Debt Current

178 K 37 K 47 K 38 K 199 K - - - - - - -

Total Non Current Liabilities

- - - 6.18 M 3.38 M 2.8 M 940 K - - 37 K 350 K 479 K

Total Current Liabilities

1.36 M 673 K 1.1 M 1.13 M 5.29 M 2.71 M 2.44 M 2.43 M 4.44 M 2.53 M 12.6 M 5.07 M

Total Liabilities

- - 3.29 K 7.31 M 8.67 M 5.5 M 3.38 M 2.43 M 4.44 M 2.57 M 13 M 5.55 M

Deferred Revenue

- - - - - - - - - - - -

Retained Earnings

-381 M -361 M - -328 M -319 M -309 M -301 M -293 M -278 M -260 M -244 M -227 M

Total Assets

40.5 M 57.7 M 64.6 K 20.2 M 13.8 M 14.2 M 18.9 M 22.8 M 29.4 M 31.9 M 57.7 M 43.5 M

Cash and Cash Equivalents

27.1 M 32.1 M 38.5 M 1.47 M 299 K 1.41 M 2.41 M 2.12 M 2.16 M 803 K 2.21 M 3.1 M

Book Value

40.5 M 57.7 M 61.3 K 12.9 M 5.17 M 8.7 M 15.5 M 20.4 M 25 M 29.3 M 44.7 M 38 M

Total Shareholders Equity

38.5 M 56.9 M 61.3 M 13.4 M 5.17 M 8.7 M 15.5 M 20.4 M 25 M 29.3 M 44.7 M 38 M

All numbers in USD currency

Quarterly Balance Sheet AIM ImmunoTech

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

139 K 283 K 950 K 495 K 543 K 597 K - 659 K 695 K 735 K 84 K 112 K 108 K 105 K 1.82 M 1.88 M 1.88 M 1.88 M 1.88 M 2.1 M 2.1 M 2.1 M 2.1 M 2.32 M 2.32 M 2.32 M 2.32 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

10.7 M 9.61 M 11.4 M 9.15 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 4.44 M 4.27 M 4.18 M 3.02 M 2.57 M 2.57 M 2.57 M 2.57 M 13 M 13 M 13 M 13 M 5.55 M 5.55 M 5.55 M 5.55 M

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-421 M -417 M -415 M -410 M -397 M -389 M - -381 M -376 M -370 M -365 M -361 M -355 M -351 M -346 M -342 M -342 M -342 M -342 M -328 M -328 M -328 M -328 M -319 M -319 M -319 M -319 M -309 M -309 M -309 M -309 M -301 M -301 M -301 M -301 M -293 M -293 M -293 M -293 M -278 M -278 M -278 M -278 M -260 M -260 M -260 M -260 M -244 M -244 M -244 M -244 M -227 M -227 M -227 M -227 M

Total Assets

13.6 M 15.7 M 16.2 M 19.4 M 27.9 M 33.6 M - 40.5 M 46.3 M 50.9 M 54.2 M 57.7 M 63.1 M 66.7 M 74.1 M 64.6 M 64.6 M 64.6 M 64.6 M 20.8 M 20.2 M 20.2 M 20.2 M 13.8 M 13.8 M 13.8 M 13.8 M 14.2 M 14.2 M 14.2 M 14.2 M 18.9 M 18.9 M 18.9 M 18.9 M 22.8 M 22.8 M 22.8 M 22.8 M 29.4 M 29.4 M 29.4 M 29.4 M 31.9 M 31.9 M 31.9 M 31.9 M 57.7 M 57.7 M 57.7 M 57.7 M 43.5 M 43.5 M 43.5 M 43.5 M

Cash and Cash Equivalents

915 K 3.55 M 3.3 M 5.44 M 15.3 M 21 M - 27.1 M 29.8 M 34.5 M 29 M 32.1 M 37.3 M 41.1 M 48.8 M 38.5 M 38.5 M 38.5 M 38.5 M 1.47 M 1.47 M 1.47 M 1.47 M 299 K 299 K 299 K 299 K 1.41 M 1.41 M 1.41 M 1.41 M 2.41 M 2.41 M 2.41 M 2.41 M 2.12 M 2.12 M 2.12 M 2.12 M 2.16 M 2.16 M 2.16 M 2.16 M 803 K 803 K 803 K 803 K 2.21 M 2.21 M 2.21 M 2.21 M 3.1 M 3.1 M 3.1 M 3.1 M

Book Value

2.91 M 6.1 M 4.83 M 10.2 M - - - 40.5 M 46.3 M 50.9 M 54.2 M 57.7 M 63.1 M 66.7 M 74.1 M 64.6 M 64.6 M 64.6 M 64.6 M 20.8 M 20.2 M 20.2 M 20.2 M 13.8 M 13.8 M 13.8 M 13.8 M 14.2 M 14.2 M 14.2 M 14.2 M 18.9 M 18.9 M 18.9 M 18.9 M 22.8 M 22.8 M 22.8 M 22.8 M 25 M 25.2 M 25.3 M 26.4 M 29.3 M 29.3 M 29.3 M 29.3 M 44.7 M 44.7 M 44.7 M 44.7 M 38 M 38 M 38 M 38 M

Total Shareholders Equity

2.91 M 6.1 M 4.83 M 10.2 M 22.6 M 30.1 M 35 M 38.5 M 42.7 M 48.8 M 53.3 M 56.9 M 62 M 65.5 M 71 M 61.3 M 61.3 M 61.3 M 61.3 M 13.4 M 12.9 M 12.9 M 12.9 M 5.58 M 5.17 M 5.17 M 5.17 M 8.7 M 8.7 M 8.7 M 8.7 M 15.5 M 15.5 M 15.5 M 15.5 M 20.4 M 20.4 M 20.4 M 20.4 M 25 M 26.4 M 25 M 25 M 29.3 M 29.3 M 29.3 M 29.3 M 44.7 M 44.7 M 44.7 M 44.7 M 38 M 38 M 38 M 38 M

All numbers in USD currency